Medicare Group Q.P.S.C (MCGS.QA) Fundamentals 2026 — P/E 25.3x, Revenue Analysis | SniperIQ
Medicare Group Q.P.S.C (MCGS.QA) is a QA-listed Healthcare company in Medical - Care Facilities with a market capitalization of QAR 1.6B, trading at QAR 5.79 on the DOH. This SniperIQ fundamentals page covers Medicare Group Q.P.S.C's valuation (P/E 25.3x, P/B 1.6x), profitability (net margin 13.2%), revenue (QAR 503M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Medicare Group Q.P.S.C's market cap?
Medicare Group Q.P.S.C (MCGS.QA) has a market capitalization of approximately QAR 1.6B, trading at QAR 5.79 on the DOH. Market cap moves with the live share price.
What is Medicare Group Q.P.S.C's P/E ratio?
Medicare Group Q.P.S.C's trailing twelve-month P/E ratio is 25.3x, with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Medicare Group Q.P.S.C?
Medicare Group Q.P.S.C runs a net profit margin of 13.2%, a gross margin of 31.3%, and an operating margin of 10.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Medicare Group Q.P.S.C generate?
Medicare Group Q.P.S.C reported revenue of QAR 503M for fiscal year 2025, with net income of QAR 76M and earnings per share (EPS) of 0.27. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Medicare Group Q.P.S.C pay a dividend?
Medicare Group Q.P.S.C offers a trailing dividend yield of about 7.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Medicare Group Q.P.S.C financially healthy?
Medicare Group Q.P.S.C carries a debt-to-equity ratio of 0.14x and a current ratio of 1.24x, with a market beta of 0.27. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Medicare Group Q.P.S.C a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medicare Group Q.P.S.C (MCGS.QA) the key facts are: market cap QAR 1.6B, P/E 25.3x, revenue QAR 503M, 52-week range 4.814-7.213. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Medicare Group Q.P.S.C's full fundamentals live
Get Medicare Group Q.P.S.C's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.